Published in J Ophthalmic Vis Res on April 01, 2011
Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology (2002) 5.10
A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology (2002) 4.10
Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol (1971) 3.64
Transconjunctival sutureless 23-gauge vitrectomy. Retina (2005) 3.44
Endophthalmitis following 25-gauge vitrectomy. Eye (Lond) (2005) 2.25
Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol (2005) 2.15
Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial). Retina (2010) 1.59
Expanded indications for 25-gauge transconjunctival vitrectomy. Jpn J Ophthalmol (2005) 1.57
PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy. Retina (2005) 1.52
Changes in corneal topography after 25-gauge transconjunctival sutureless vitrectomy versus after 20-gauge standard vitrectomy. Ophthalmology (2007) 1.49
Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2010) 1.33
25-Gauge pars plicata vitrectomy for stage 4 and 5 retinopathy of prematurity. Retina (2006) 1.18
The vitreous gel: more than meets the eye. Am J Ophthalmol (2009) 1.08
Pharmacologic vitreolysis. Retina (1998) 1.00
Ultrasound biomicroscopy study of direct and oblique 25-gauge vitrectomy sclerotomies. Am J Ophthalmol (2007) 0.97
Two-step oblique incision during 25-gauge vitrectomy reduces incidence of postoperative hypotony. Clin Experiment Ophthalmol (2007) 0.88
Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery. Retina (2006) 0.88
Pharmacologic vitreolysis with plasmin and hyaluronidase in diabetic rats. Retina (2009) 0.87
Cystatin C uptake in the eye. Graefes Arch Clin Exp Ophthalmol (2004) 0.84
Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci (2004) 0.84
Changes in higher-order aberrations after scleral buckling surgery for rhegmatogenous retinal detachment. Ophthalmology (2007) 0.83
Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis. Jpn J Ophthalmol (2008) 0.83
Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery. Curr Eye Res (2010) 0.83
Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion. Retina (2007) 0.81
Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis. Invest Ophthalmol Vis Sci (2006) 0.81
Computer briefs: personalized medicine. J Med Pract Manage (2010) 0.77
Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment: six-month follow-up results of a single operation--report no. 1. Ophthalmology (2005) 3.33
Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol (2007) 2.51
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up. Graefes Arch Clin Exp Ophthalmol (2009) 1.41
Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Ophthalmology (2009) 1.38
Epidemiology of childhood ocular trauma in a northeastern Colombian region. Arch Ophthalmol (2003) 1.31
Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology (2009) 1.15
Vitreoretinal disorders in anterior megalophthalmos. Jpn J Ophthalmol (2006) 1.11
Foveal thickness and macular volume in patients with oculocutaneous albinism. Retina (2007) 0.97
Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study. Ophthalmology (2010) 0.90
Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia. Retina (2008) 0.88
Sclerochoroidal calcification is primarily a scleral condition based on enhanced depth imaging optical coherence tomography. JAMA Ophthalmol (2013) 0.85
Oral propranolol for exudative retinal detachment in diffuse choroidal hemangioma. Arch Ophthalmol (2011) 0.85
Multifocal choroiditis in a diabetic patient. J Ophthalmic Vis Res (2011) 0.83
Crystalline retinopathy associated with retinal dialysis and chronic retinal detachment. Retina (2003) 0.81
En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy. Ophthalmology (2008) 0.81
INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: 5-Year Results of The Pan-American Collaborative Retina Study Group. Retina (2016) 0.80
Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part II. Clin Ophthalmol (2013) 0.79
A Novel Curvature-Based Algorithm for Automatic Grading of Retinal Blood Vessel Tortuosity. IEEE J Biomed Health Inform (2015) 0.79
Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part I. Clin Ophthalmol (2013) 0.78
Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema. Acta Ophthalmol (2011) 0.77
Unilateral decreased vision in a middle-aged man. J Ophthalmic Vis Res (2013) 0.75
Switching Anti-VEGF Drugs in the Treatment of Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina (2017) 0.75
Macular disease affects the outcome of ZyWave aberrometry. Ophthalmic Surg Lasers Imaging (2010) 0.75
Bilateral Combined Hamartomas of the Retina and Retinal Pigment Epithelium as the Presenting Feature of Neurofibromatosis Type 2 (Wishart Type). J Pediatr Ophthalmol Strabismus (2014) 0.75
Minimal refractive change induced by sutureless 23- and 25-gauge pars plana vitrectomy. Ophthalmic Surg Lasers Imaging (2012) 0.75
8 Questions with Darius Moshfeghi. Ophthalmic Surg Lasers Imaging Retina (2017) 0.75
Safety evaluation of nanoliposomes containing cyclosporine a after ocular administration. Curr Eye Res (2012) 0.75
Bilateral combined hamartomas of the retina and retinal pigment epithelium as the presenting feature of neurofibromatosis type 2 (Wishart Type). J Pediatr Ophthalmol Strabismus (2014) 0.75